Canbex Therapeutics
Latest round
- Series A
Last raised
- Apr 2013
Total raised
- $6.5M
Investors
- 5
About Canbex Therapeutics
Canbex Therapeutics Ltd is dedicated to the development of novel compounds for the treatment of spasticity in multiple sclerosis (MS) and potentially other disorders.
Who invested in Canbex Therapeutics
5 investors across 2 rounds
See all investors in Canbex Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Canbex Therapeutics
Who invested in Canbex Therapeutics?
Canbex Therapeutics has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Canbex Therapeutics raised?
Canbex Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Canbex Therapeutics last raise money?
Canbex Therapeutics's most recent round on record is a Series A, in Apr 2013.
What does Canbex Therapeutics do?
Canbex Therapeutics Ltd is dedicated to the development of novel compounds for the treatment of spasticity in multiple sclerosis (MS) and potentially other disorders.
Where is Canbex Therapeutics headquartered?
Canbex Therapeutics is headquartered in London, UK.
Which VCs invest in companies like Canbex Therapeutics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back pharmaceuticals companies at Canbex Therapeutics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Canbex Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.